CKRT draws on expert preceptors across Yale and UConn Health, spanning the kidney, urologic, and hematologic disciplines and research areas from genomics and epidemiology to bioengineering, computational science, and clinical trials.
Every appointed trainee works with a primary research mentor — each of whom has completed mentor training and been approved by the Administrative Committee — together with a secondary mentor at the partnering institution and a broader mentoring team focused on research success and career development.
Names link to each mentor’s institutional faculty profile. Mentors are grouped by primary discipline; several work across areas.
Kidney
Pediatric hypertension, biomarkers, and epigenetics.
Genetic mechanisms in polycystic kidney disease.
Cytoskeleton, autophagy, apoptosis, aging, and kidney disease.
Epithelial cell physiology and polycystic kidney disease.
Hypertension, diabetes, acute kidney injury, and catecholamine metabolism.
Acute and chronic kidney injury and health disparities in kidney disease.
Steroid microenvironments and vascular inflammation.
Acute kidney injury and chronic kidney disease.
Angiopoietin pathway and outcomes after deceased-donor kidney transplantation.
Pediatric nephrology, including pediatric kidney stone disease.
Mechanisms of proteinuria and translational studies in native and allograft fibrosis.
Acute interstitial nephritis and kidney biopsy.
Genetic kidney and liver disease; cilia function and polycystin biology.
Zebrafish genetics, cilia, kidney development, and polycystic kidney disease.
Acute kidney injury, digital health, and randomized and pragmatic trials.
Acute kidney injury and chronic kidney disease.
Pathogenesis and therapeutics of acute kidney injury.
Urologic
Urinary biomarkers of aging.
Management of benign and malignant prostate disease.
Geroscience-guided approaches to voiding, continence, mobility, and host defense.
Prostate cancer, comparative effectiveness research, screening, and early detection.
Targeting urologic diseases and their immune microenvironments.
Female pelvic floor disorders, lower urinary tract dysfunction, and patient-reported outcomes.
Hematologic
Novel therapeutics for sickle cell disease.
Sickle cell disease, AYA transition, implementation science, and health outcomes.
Classical hematology and bleeding disorders.
Cell fate control, reprogramming, and hematopoietic stem and progenitor cells.
Hematopoiesis, leukemia, myelodysplastic syndromes, and alternative splicing.
Platelet signaling and function and platelet-targeted therapeutics.
Hematopoiesis and bone marrow transplantation.
Hemoglobinopathies and hematopoietic stem cell transplantation.
Hematopoiesis, myeloid cell function, and noncoding RNAs.
Myeloid malignancies and bone marrow / stem cell transplant.
Links between transcription and splicing and the role of cellular sub-compartments in RNA biogenesis.
Hematopoietic stem cell biology, clonal hematopoiesis, and hematopoietic development of human iPSCs.
Molecular and biochemical regulation of hematopoiesis in normal and disease states.
Hematopoiesis and the bone marrow microenvironment.
Vascular and endothelial cell biology and vesicular trafficking.
Cross-disciplinary & quantitative
T cell differentiation and function in immunity and autoimmunity.
Systemic sclerosis (scleroderma).
Fibroblast growth factors and their receptors in disorders of bone, kidney, and blood.
Cardiovascular and cardiorenal medicine.
Statistical genomics and proteomics, genome-wide association studies, and biomarker identification.
assets/img/faculty/ to add them to the cards.